Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-03

Clinical Trial Update: SpecTRA; An Observational Study of the Verification of Protein Biomarkers in Transient Ischemic Attack.

View source ↗

Summary

SpecTRA is an observational study evaluating protein biomarkers in transient ischemic attack, with the trial status shown as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Andrew Penn | Conditions: TIA | Status: COMPLETED